What are protocols for intravesical adjuvant immunotherapy in non–muscle invasive bladder cancer?

Updated: Feb 23, 2021
  • Author: Gary David Steinberg, MD, FACS; Chief Editor: E Jason Abel, MD  more...
  • Print


BCG 81 mg (TheraCys) or 50 mg (TICE BCG) in 50 mL sterile saline instilled into the bladder through a catheter and held for 2 h; instilled weekly for 6 wk [4]

Maintenance therapy: 81 mg intravesically given on days 1, 8, and 15 of months 3, 6, 12, 18, 24, and 36 after initiation

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!